This page has been robot translated, sorry for typos if any. Original content here.

Attention! The information is for reference only!
Before taking, be sure to consult a doctor!
SITE ONLY DIRECTORY. NOT A PHARMACY! We do not sell medicines! None!

Medicines affecting the muscles of the uterus (uterine drugs)

Until recent years, uterine drugs were mainly treated as agents that increase the tone and enhance the contractile activity of the myometrium (ergot drugs, oxytocin, etc.). If necessary, to reduce contractile activity and tone of the uterus, sedatives, anesthetics (nitrous oxide, ether, fluorotan, etc.), antispasmodics and anticholinergics were used.
In recent years, the arsenal of uterine funds has expanded significantly. New highly active agents appeared that stimulate the myometrium (from the group of prostaglandins) and new drugs that inhibit the contractile activity of the uterus (mainly from the group of Ab adrenostimulants), called “tocolytics” (from the tocus genus).
Thus, at present, uterine drugs are divided into 2 main groups: a) funds that stimulate the muscles of the uterus (oxytocic drugs), and b) drugs that lower the tone and contractile activity of the uterus (tocolytics).
The first group includes oxytocin, ergot drugs, prostaglandins, etc. Recently, b-adrenergic blocking agents have also been used to stimulate labor activity (see Anaprilin).
Tocolytics are mainly drugs from the group
A b -adrenostimulants (partusisten, fenoterol, sulbupart, ritodrin, etc.).
The group Means that affect the muscles of the uterus (uterine funds) includes the following groups: